Information Library

Results for: Cost control/reduction - Flexible outsourcing - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Outsourcing as strategic alternative to your own headcount

    Presentation — May 25, 2010
    Approach of Roche Italy in outsourcing their primary care sales force to Quintiles

  • Focused Co-Promotion

    Case Study — May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • The Power of Consolidation: How to Gain Efficiencies without Sacrificing Quality

    Case Study — March 31, 2010
    Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management.

  • Geoff Garabedian

    Hear from the Experts — March 25, 2009
    As Practice Leader for Regulatory and Quality in the U.S., Geoff combines a strong management consulting background with specific experience in the regulatory and compliance arena, including design and implementation of large-scale process, organization and technology transformations.

  • Jim Featherstone, Ph.D.

    Hear from the Experts — March 25, 2009
    Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

  • Podcast: A New Gold Standard

    Hear from the Experts — May 1, 2008
    John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences